S

Syngene International Ltd

Labs & Life Sciences ServicesSmallcap

About the company

Syngene International Limited is a contract research company. It is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 7 analysts offering recommendations for Syngene International Ltd

72%

Buy

14%

Hold

14%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio59.4340.00
PB Ratio3.985.93
Dividend Yield0.27%0.57%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions